The Medical Device Directives and The Revision

An essential update on the revision of the Medical Device Directives and practical guidance on how to interpret and comply with the new regulations.

During this time of ongoing regulatory activity, Informa Life Sciences’ 8th Annual The Medical Device Directives and the Revision is essential to provide a better understanding the legal framework as it stands now in Europe. The meeting offers valuable practical advice on how to manage the many continuous challenges which need to be overcome in order to remain fully compliant with the regulations.

The conference will provide a crucial update on the proposed changes that are currently under revision by the European Commission, including perspectives from Competent Authority, Notified Body and industry angles.

Every body

UK • Anwen Evans, UK • Chris Jepson, Belgium Notified Bodies • Gert Bos, The Netherlands • Augustin Coppee, Ireland • Stefan Visscher, Competent Authorities • Niall MacAleenan, Hunton & Williams, Counsel, Axon Lawyers, partner, Clinica Medtech Intelligence, Medtech Regulatory Affairs Editor, Johnson & Johnson, Director Regulatory Affairs EMEA Global Surgery Group, Institut Straumann AG, Head of Risk Management, Product Safety Officer, Regulatory Affairs Leader EMEA, Smith & Nephew Orthopaedics AG, Manager Vigilance, Agfa HealthCare, COCIR's Software Task force and QARA Manager, Deputy Chair, CROMA Pharma GmbH, Director Regulatory Affairs and Legal, Geistlich Pharma AG, Head of Global Regulatory Affairs, Boston Scientific, Senior Fellow, CRM Clinical, Belgium, Alcon, Authorised Representative MDD, Surgical and Vision Care, Director Regulatory Affairs EURMEA, Medtronic GmbH, Director Regulatory Affairs & Policy Europe, GE Healthcare, Global Head of Regulatory - Dx Life Sciences, Notified Body 0123, TÜV SÜD Product Service GmbH, Division Manager, DEKRA Certification, The Netherlands • Geneviève Michaux, UK • Erik Vollebregt, Germany • Amanda Maxwell, Switzerland

• Conferences & Trade Shows Today